BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 17117469)

  • 1. Controlled release of nerve growth factor from fibrin gel.
    Bhang SH; Jeon O; Choi CY; Kwon YH; Kim BS
    J Biomed Mater Res A; 2007 Mar; 80(4):998-1002. PubMed ID: 17117469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of the controlled release of nerve growth factor from collagen gel on the efficiency of neural cell culture.
    Bhang SH; Lee TJ; Lim JM; Lim JS; Han AM; Choi CY; Kwon YH; Kim BS
    Biomaterials; 2009 Jan; 30(1):126-32. PubMed ID: 18838157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term and zero-order release of basic fibroblast growth factor from heparin-conjugated poly(L-lactide-co-glycolide) nanospheres and fibrin gel.
    Jeon O; Kang SW; Lim HW; Hyung Chung J; Kim BS
    Biomaterials; 2006 Mar; 27(8):1598-607. PubMed ID: 16146647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Silk fibroin matrices for the controlled release of nerve growth factor (NGF).
    Uebersax L; Mattotti M; Papaloïzos M; Merkle HP; Gander B; Meinel L
    Biomaterials; 2007 Oct; 28(30):4449-60. PubMed ID: 17643485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Release rate controls biological activity of nerve growth factor released from fibrin matrices containing affinity-based delivery systems.
    Wood MD; Sakiyama-Elbert SE
    J Biomed Mater Res A; 2008 Feb; 84(2):300-12. PubMed ID: 17607752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Controlled release of neurotrophin-3 from fibrin gels for spinal cord injury.
    Taylor SJ; McDonald JW; Sakiyama-Elbert SE
    J Control Release; 2004 Aug; 98(2):281-94. PubMed ID: 15262419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sustained delivery of bioactive cytokine using a dense collagen gel vehicle collagen gel delivery of bioactive cytokine.
    Premaraj S; Mundy BL; Morgan D; Winnard PL; Mooney MP; Moursi AM
    Arch Oral Biol; 2006 Apr; 51(4):325-33. PubMed ID: 16226216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polycaprolactone and bovine serum albumin based nanofibers for controlled release of nerve growth factor.
    Valmikinathan CM; Defroda S; Yu X
    Biomacromolecules; 2009 May; 10(5):1084-9. PubMed ID: 19323510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ionically cross-linked chitosan microspheres for controlled release of bioactive nerve growth factor.
    Zeng W; Huang J; Hu X; Xiao W; Rong M; Yuan Z; Luo Z
    Int J Pharm; 2011 Dec; 421(2):283-90. PubMed ID: 22001532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced nerve growth factor efficiency in neural cell culture by immobilization on the culture substrate.
    Bhang SH; Lee TJ; Yang HS; La WG; Han AM; Kwon YH; Kim BS
    Biochem Biophys Res Commun; 2009 May; 382(2):315-20. PubMed ID: 19275890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immobilized concentration gradients of nerve growth factor guide neurite outgrowth.
    Kapur TA; Shoichet MS
    J Biomed Mater Res A; 2004 Feb; 68(2):235-43. PubMed ID: 14704965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of anti-Fas ligand-induced apoptosis and neural differentiation of PC12 cells treated with nerve growth factor using small interfering RNA method and sampling by microdialysis.
    Chiou SH; Kao CL; Chang YL; Ku HH; Tsai YJ; Lin HT; Yen CJ; Peng CH; Chiu JH; Tsai TH
    Anal Biochem; 2007 Apr; 363(1):46-57. PubMed ID: 17306206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Siatic nerve regeneration in rats stimulated by fibrin glue containing nerve growth factor: an experimental study.
    Gao C; Ma S; Ji Y; Wang JE; Li J
    Injury; 2008 Dec; 39(12):1414-20. PubMed ID: 18715558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rationally designed peptides for controlled release of nerve growth factor from fibrin matrices.
    Willerth SM; Johnson PJ; Maxwell DJ; Parsons SR; Doukas ME; Sakiyama-Elbert SE
    J Biomed Mater Res A; 2007 Jan; 80(1):13-23. PubMed ID: 16958043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using NGF heparin-poloxamer thermosensitive hydrogels to enhance the nerve regeneration for spinal cord injury.
    Zhao YZ; Jiang X; Xiao J; Lin Q; Yu WZ; Tian FR; Mao KL; Yang W; Wong HL; Lu CT
    Acta Biomater; 2016 Jan; 29():71-80. PubMed ID: 26472614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Control of basic fibroblast growth factor release from fibrin gel with heparin and concentrations of fibrinogen and thrombin.
    Jeon O; Ryu SH; Chung JH; Kim BS
    J Control Release; 2005 Jul; 105(3):249-59. PubMed ID: 16088988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BDNF, NT-3, and NGF released from transplanted neural progenitor cells promote corticospinal axon growth in organotypic cocultures.
    Kamei N; Tanaka N; Oishi Y; Hamasaki T; Nakanishi K; Sakai N; Ochi M
    Spine (Phila Pa 1976); 2007 May; 32(12):1272-8. PubMed ID: 17515814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Controlled release of nerve growth factor enhances sciatic nerve regeneration.
    Lee AC; Yu VM; Lowe JB; Brenner MJ; Hunter DA; Mackinnon SE; Sakiyama-Elbert SE
    Exp Neurol; 2003 Nov; 184(1):295-303. PubMed ID: 14637100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heat shock enhances NGF-induced neurite elongation which is not mediated by Hsp25 in PC12 cells.
    Read DE; Reed Herbert K; Gorman AM
    Brain Res; 2008 Jul; 1221():14-23. PubMed ID: 18561899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of controlled release nerve growth factor on repairing peripheral nerve defect by acellular nerve graft].
    Yu H; Peng J; Sun H; Xu F; Zhang L; Zhao B; Sui X; Xu W; Lu S
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2008 Nov; 22(11):1373-7. PubMed ID: 19068610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.